Flores named Pediatric Infectious Diseases division chief

By Roman Petrowski, Office of Communications

Anthony Flores - Pediatric Infectious Diseases
Anthony Flores, MD, PhD

Anthony R. Flores, MD, PhD, associate professor in the Department of Pediatrics has been named chief of the Division of Pediatric Infectious Diseases, effective July 1, 2021. Flores succeeds Gloria Heresi, MD, who held the position for the last decade.

“I am incredibly grateful to Dr. Mary Aitken and the Department of Pediatrics for giving me this opportunity,” Flores said. “I am excited to build upon the hard work of Dr. Gloria Heresi and looking forward to working with departmental leadership toward further strengthening the division.”

Flores completed his MD, MPH, and PhD, at the University of Rochester School of Medicine and Dentistry, followed by a residency in pediatrics and a fellowship in infectious diseases at Baylor College of Medicine. He joined the Department of Pediatrics in 2017.

Through support from the Pediatric Infectious Diseases Society (PIDS) and the Robert Wood Johnson Foundation, he developed a robust research program in streptococcal pathogenesis during his fellowship and early faculty years.

Flores’ current research focuses on the genomic epidemiology and virulence mechanisms of pathogenic streptococci (group A and B streptococci) and is funded by grant awards for the NIH/NIAID. Through is primary research and collaborative efforts, Flores has published over 50 peer-reviewed articles and several book chapters.

In addition to pediatric infectious diseases consultations and research, Flores has a strong interest in mentoring trainees and early career physician-scientists aimed at improving workforce diversity in pediatrics and research. In 2019, he spearheaded the formation and is the co-chair of the Inclusion, Diversity, Access, & Equity (IDA&E) Task Force in PIDS. Through the task force, he has led the collaboration between PIDS and the Academic Pediatric Association’s RAPID program to provide mentorship to early-stage investigators underrepresented in medicine and is part of the National Advisory Committee in the PIDS/APA RAPID Collaborative.